# NAD+ Decline in Menopause: Real Biology, Thin Human Evidence So Far

*Nicotinamide Adenine Dinucleotide and Its Anti-aging Effects in the Context of Longevity and Menopause.*

- **Evidence Level**: Preliminary
- **Publication Types**: Journal Article
- **Journal**: Mini reviews in medicinal chemistry
- **Sample Size**: N/A
- **Authors**: Alp Arici EC, Küpeli Akkol E, Sobarzo-Sánchez E, Selamoglu Z
- **Published**: 2026-08-18
- **Topics**: NAD+, nicotinamide riboside, menopause
- **DOI**: https://doi.org/10.2174/0113895575469704260805105227
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42669985/

## Summary

NAD+ is the molecule your cells use to make energy and repair DNA, and levels drop as you age. This review looks specifically at menopause, when falling estrogen adds mitochondrial problems, inflammation and oxidative stress on top of normal aging. Precursors like NMN and nicotinamide riboside (NR) look good in lab and animal work. In people, results vary a lot and long-term safety data are still missing.

## Practical Takeaway

This review suggests NAD+ boosters remain unproven for menopausal health despite promising lab results.

---

_Canonical: https://longevity-germany.com/en/research/nad-decline-in-menopause-real-biology-thin-human-evidence-so-far · Part of Longevity Cities · Updated 2026-08-18_